183 results on '"M. Milh"'
Search Results
2. Apport de la génétique dans la prise en charge des épilepsies de l’enfant
- Author
-
C. Bar and M. Milh
- Subjects
General Medicine - Published
- 2022
3. Mouvements oculaires anormaux chez le nourrisson
- Author
-
M. Milh and E. Bui Quoc
- Subjects
General Medicine - Published
- 2022
4. Objective evaluation of clinical actionability for genes involved in myopathies: 63 genes with a medical value for patient care
- Author
-
M. Vecten, E. Pion, M. Bartoli, R. Juntas Morales, D. Sternberg, J. Rendu, T. Stojkovic, C. Acquaviva Bourdain, C. Métay, I. Richard, M. Cerino, M. Milh, S. Gorokhova, N. Levy, X. Latypova, G. Bonne, V. Biancalana, F. Petit, A. Molon, A. Perrin, P. Laforet, S. Attarian, M. Cossée, and M. Krahn
- Abstract
The implementation of high-throughput diagnostic sequencing has led to the generation of large amounts of mutational data, making their interpretation more complex and responsible for long delays. It has been important to prioritize certain analyses, particularly those of “actionable” genes in diagnostic situations, involving specific treatment and/or management. In our project, we carried out an objective assessment of the clinical actionability of genes involved in myopathies, for which only few data obtained methodologically exist to date. Using the ClinGen Actionability criteria, we scored the clinical actionability of all 199 genes implicated in myopathies published by FILNEMUS for the “National French consensus on gene Lists for the diagnosis of myopathies using next generation sequencing”. We objectified that 63 myopathy genes were actionable with currently available data. Among the 36 myopathy genes with highest actionability scores, only 8 had been scored to date by ClinGen. The data obtained through these methodological tools are an important resource for strategic choices in diagnostic approaches and the management of genetic myopathies. The clinical actionability of genes has to be considered as an evolving concept, in relation to progresses in disease knowledge and therapeutic approaches.
- Published
- 2022
5. Transition from paediatric to adult care in adolescents with neurological diseases and handicap
- Author
-
B. Chabrol, M. Milh, Hôpital de la Timone [CHU - APHM] (TIMONE), Anthropologie bio-culturelle, Droit, Ethique et Santé (ADES), and Aix Marseille Université (AMU)-EFS ALPES MEDITERRANEE-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Adult ,Transition to Adult Care ,Adolescent ,[SDV]Life Sciences [q-bio] ,Intellectual disability ,Adult care ,MESH: Nervous System Diseases ,Cerebral palsy ,Educational therapy ,Young Adult ,03 medical and health sciences ,MESH: Patient Care Team ,0302 clinical medicine ,Multidisciplinary approach ,MESH: Child ,Humans ,Medicine ,030212 general & internal medicine ,Child ,Paediatric care ,MESH: Adolescent ,Patient Care Team ,Epilepsy ,MESH: Humans ,business.industry ,Cerebral Palsy ,MESH: Transition to Adult Care ,MESH: Adult ,medicine.disease ,Disabled Children ,Chronic disorders ,3. Good health ,Active participation ,Neurology ,MESH: Young Adult ,MESH: Disabled Children ,MESH: Interdisciplinary Communication ,Interdisciplinary Communication ,Neurology (clinical) ,Medical emergency ,Nervous System Diseases ,business ,030217 neurology & neurosurgery ,Neurological diseases - Abstract
International audience; The transfer of adolescents from paediatric care to adult health facilities is often difficult for the patients and their families and can lead to a breakdown in medical follow-up and therefore serious complications. Existing recommendations for the successful transition of patients with chronic disorders do not specifically address patients with handicap. Preparations for the transfer must be made well in advance. They must aim to achieve the autonomisation of adolescents by making them responsible and providing them with the knowledge that will enable them to manage their care themselves, the know-how to react appropriately if there is any change in their condition, and to move comfortably within the adult health system. This requires the active participation of the patient, his or her family and the paediatric and adult care teams. It involves multidisciplinary management plus the production and maintenance of an educational therapy programme. Finally, the identification of doctors trained in handicap, relevant sub-specialists and even expert patients could enable improvements in the continuum of complete and appropriate care for these patients within adult medicine.
- Published
- 2020
6. Overview of therapeutic options for epilepsy
- Author
-
M, Kuchenbuch, C, Chiron, and M, Milh
- Subjects
Pediatrics, Perinatology and Child Health - Abstract
Tuberous sclerosis (TSC) epilepsy includes infantile spasms and focal seizures before the age of 2 years, whereas focal seizures are predominant over 2 years and generalized seizures may occasionally be part of Lennox-Gastaut syndrome. The better and earlier the seizure control, the better the child's subsequent cognitive and behavioral prognosis. As for epilepsy of other causes, therapeutic options depend on the type of seizure/epilepsy, age and drug resistance, but there are significant specificities for TSC. (1) As first-line treatment, vigabatrin is unanimously recommended for infantile spasms and focal seizures before 2 years and is also widely used for seizures over 2 years, as are levetiracetam and carbamazepine. (2) If seizures persist (about 40% of children and adolescents), cannabidiol and everolimus, an inhibitor of the mTOR pathway, have recently been approved as adjunctive therapy to the arsenal of antiseizure medications authorized for this age group and to the ketogenic diet. (3) Surgery is an essential treatment option in cases of drug resistance and should be discussed as soon as two treatments have failed. Presurgical investigations and operating techniques have recently progressed spectacularly, for example laser thermocoagulation with stereotactic location. A particularity of TSC is the possibility of sequential interventions on several epileptogenic tubers. (4) Finally, the innovative principle of initiating "pre-seizure" treatment with vigabatrin from the first months of life has just proven effective on the subsequent development of epilepsy in TSC. © 2022 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.
- Published
- 2022
7. Pediatric emergency room visits for neurological conditions: Description and use of pediatric neurologist advice
- Author
-
Brigitte Chabrol, F. Albertini, V. Bresson, M. Milh, S. Tardieu, Hôpital de la Timone [CHU - APHM] (TIMONE), Anthropologie bio-culturelle, Droit, Ethique et Santé (ADES), and Aix Marseille Université (AMU)-EFS ALPES MEDITERRANEE-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Male ,Pediatric emergency ,medicine.medical_specialty ,Adolescent ,[SDV]Life Sciences [q-bio] ,Hospitals, University ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,Febrile seizure ,medicine ,Humans ,Neurologists ,Quality of care ,Child ,Referral and Consultation ,Retrospective Studies ,Pediatric ,business.industry ,Incidence ,Incidence (epidemiology) ,Infant, Newborn ,Pediatric neurologist ,Infant ,Emergency department ,medicine.disease ,3. Good health ,Migraine ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Emergency medicine ,Neurological ,Female ,Neuropediatrician ,France ,Epileptic seizure ,Nervous System Diseases ,medicine.symptom ,Emergencies ,Emergency Service, Hospital ,business ,030217 neurology & neurosurgery - Abstract
Introduction and objective Information on the spectrum and frequencies of pediatric neurological presentations to emergency departments is vital to optimize quality of care. The objective of this study was to determine the incidence of pediatric neurological emergencies and to analyze the impact of specialist neurological advice in emergency care. Patients and methods We performed a retrospective descriptive study of pediatric emergency room visits for neurological reasons at the Timone University Hospital in Marseille over a 6-month period (from October 2017 to March 2018). Results Of the 14,572 emergencies analyzed, 370 (2.5%) were for neurological conditions. These were most commonly seizures (56.7% of cases), headache (19.7%), and motor or sensory deficits (5.1%). The most frequent diagnosis was epileptic seizure (30%), followed by febrile seizure (26.1%) and migraine (15%). Around two in every five patients (37.6%) required hospitalization. Neurological emergencies requiring critical care occurred at a frequency of about one per month (1.6% of cases). A pediatric neurologist was consulted in 37.3% of cases, resulting in a modification of the diagnosis or treatment in 66% of these referrals. Conclusion The results of this study suggest that a formal referral system between the emergency department and pediatric neurologists would be useful.
- Published
- 2020
8. Étude du fonctionnement adaptatif d’adultes présentant une déficience intellectuelle : rôles des apprentissages réalisés dans l’enfance, de l’âge et du quotient intellectuel ; étude préliminaire observationnelle de 16 adultes
- Author
-
A. Minguez and M. Milh
- Subjects
Age effect ,education ,Wechsler Adult Intelligence Scale ,Cognition ,behavioral disciplines and activities ,Developmental psychology ,Adaptive functioning ,Intellectual quotient ,03 medical and health sciences ,0302 clinical medicine ,Social skills ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,Communication skills ,Psychology - Abstract
The objective of this study was to investigate the adaptive functioning of adults who had a slight to moderate intellectual deficiency, in regard of age and intellectual quotient (IQ). Cognitive and adaptive functioning were evaluated using the WAIS and VINELAND scales in 16 adults who accepted to participate in this study. We found a correlation between global IQ and each domain of the adaptive score, mostly communication skills. We also found that there was an age effect on socialization skills. Most skills were learned during infancy and adolescence, especially communication skills, which are highly stable at different ages and highly correlated with IQ. However, some abilities are still acquired in adulthood, mostly socialization skills, especially in persons with the lowest IQ. These data are of particular interest for people caring for disabled adults.
- Published
- 2018
9. Gestion prénatale des fœtus avec un périmètre crânien inférieur au 3 e percentile
- Author
-
P. Mace, M. Milh, N. Girard, S. Sigaudy, and E. Quarello
- Subjects
Maternity and Midwifery - Published
- 2017
10. Desarrollo neurológico
- Author
-
J. Mancini, M. Milh, and B. Chabrol
- Published
- 2015
11. [How to deal with a fetal head circumference lower than the third percentile?]
- Author
-
P, Mace, M, Milh, N, Girard, S, Sigaudy, and E, Quarello
- Subjects
Cephalometry ,Pregnancy ,Zika Virus Infection ,Microcephaly ,Humans ,Female ,Ultrasonography, Prenatal - Abstract
The prenatal finding of a head circumference (HC) below the 3rd percentile (p) remains, in the same way as short femur or increased nuchal translucency with normal karyotype, one the most difficult situations for the praticionner in the setting of prenatal diagnosis. Microcephaly is a gateway to possible cerebral pathologies, but the main objective is to identify serious prenatal situations. A standardized HC measurement, the use of adapted reference tools and charts, longitudinal following of cephalic biometrics in high-risk situations, and systematic central nervous system analysis can increase the diagnostic performance of ultrasound which is often disappointing for microcephaly. The early distinction between associated or isolated microcephaly makes it possible to quickly orient the prenatal management and counseling. Fetal MRI and genetic counseling are fundamental in this context, making it possible to specify at best the etiological diagnosis and to provide assistance to the neuropediatrician in the establishment of an often uncertain prognosis. The recent increase in cases of microcephaly concomitant with the epidemic of the ZIKA virus is an additional argument to improve our practices and the daily apprehension of HC3rd p.
- Published
- 2017
12. [Evaluating a child after a febrile seizure: Insights on three important issues]
- Author
-
S, Auvin, M, Antonios, G, Benoist, M-A, Dommergues, F, Corrard, V, Gajdos, C, Gras Leguen, E, Launay, A, Salaün, L, Titomanlio, L, Vallée, and M, Milh
- Subjects
Humans ,Child ,Seizures, Febrile - Abstract
Febrile seizures (FS) are the most common seizures seen in the paediatric population in the out-of-hospital and emergency department settings, and they account for the majority of seizures seen in children younger than 5 years old. An FS is a seizure accompanied by fever, without central nervous system infection, occurring in children between 6 months and 5 years old. Five criteria have been used and taught to classify any FS as simple or complex FS. These factors do not bear the same significance for clinical practice, in particular, the decision to perform a lumbar puncture for cerebrospinal fluid analysis to rule out an intracranial infection. Moreover, epidemiological studies have illustrated that some factors are predictive of febrile seizure recurrence while others are predictive of epilepsy occurrence. On this basis, a workshop was organized to provide an answer to three clinical practice questions: when should a lumbar puncture be performed in a child who has experienced a seizure during a fever episode, is the prescription of a rescue drug required with a risk of a prolonged febrile seizure recurrence, when should a neurological consultation be requested (risk of later epilepsy)? Based on a review of the literature and on a 1-day workshop, we report here the conclusion of the working group. A lumbar puncture is required in any child with meningitis symptoms or septic signs or behaviour disturbance. A lumbar puncture should be discussed based on the clinical symptoms and their progression over time when a child has experienced a focal FS or repetitive FSs without signs of meningitis or sepsis or behaviour disturbance. The lumbar puncture is not necessary in case of simple FS without signs of meningitis, including in infants between 6 and 12 months old. An early clinical evaluation (at least 4 h after the first clinical assessment) could be helpful, in particular in infants younger than 12 months of age. A rescue drug might be prescribed when there is a high risk of prolonged FS (i.e., risk higher than 20%): age at FS12months OR a history of a previous febrile status epilepticus OR if the first FS was a focal seizure OR abnormal development/neurological exam/MRI OR a family history of nonfebrile seizure. A neurological consultation should be requested for any child who has experienced a prolonged FS before the age of 1 year, for children who have experienced prolonged and focal FS or repetitive (within 24h) focal FS, for children who have experienced multiple complex (focal or prolonged or repetitive) FS, for children with an abnormal neurological exam or abnormal development experiencing a FS. Although childhood febrile seizures in most cases are benign, witnessing such seizures is always a terrifying experience for the child's parents. Most parents feel that their child is dying or could have severe brain injury related to the episode. Therefore, the group also suggests a post-FS visit with the primary care physician.
- Published
- 2017
13. [Adaptive functioning in adults with intellectual deficiency: Role of skills during childhood, age, and IQ in a preliminary study of 16 adults]
- Author
-
A, Minguez and M, Milh
- Subjects
Adult ,Male ,Communication ,Intelligence ,Age Factors ,Middle Aged ,Social Skills ,Young Adult ,Cognition ,Intellectual Disability ,Adaptation, Psychological ,Humans ,Female ,Prospective Studies - Abstract
The objective of this study was to investigate the adaptive functioning of adults who had a slight to moderate intellectual deficiency, in regard of age and intellectual quotient (IQ). Cognitive and adaptive functioning were evaluated using the WAIS and VINELAND scales in 16 adults who accepted to participate in this study. We found a correlation between global IQ and each domain of the adaptive score, mostly communication skills. We also found that there was an age effect on socialization skills. Most skills were learned during infancy and adolescence, especially communication skills, which are highly stable at different ages and highly correlated with IQ. However, some abilities are still acquired in adulthood, mostly socialization skills, especially in persons with the lowest IQ. These data are of particular interest for people caring for disabled adults.
- Published
- 2016
14. Résultats et complications de l’hémisphérotomie verticale para sagittale chez le jeune enfant. À propos de 11 cas
- Author
-
Anne Lépine, Nathalie Villeneuve, Didier Scavarda, G. Pech Gourg, S.M. Florea, and M. Milh
- Subjects
Surgery ,Neurology (clinical) - Abstract
Introduction L‘hemispherotomie verticale para sagittale decrite par O. Delalande est un geste neurochirurgical de deconnection hemispherique. Elle est indiquee dans le traitement des epilepsies refractaires dont la zone epileptogene est largement etendue sur un hemisphere. Nous rapportons notre experience des dix dernieres annees. Materiel et methodes Entre 2008 et 2018, 11 patients (6 filles et 5 garcons) ont beneficie d’une hemispherotomie verticale para sagittale pour une epilepsie refractaire au traitement medicamenteux bien conduit dans le service de Neurochirurgie pediatrique de Marseille. Tous les patients ont beneficie d’un bilan pre operatoire complet (EEG, Video EEG, Pet Scan, IRM, Bilan neuropsychologique) et ont ete discute en reunion multidisciplinaire de chirurgie de l’epilepsie pediatrique. Tous les enfants ont beneficie de la technique de Delalande. Ils ont ete revus en consultation a 1 mois, 6 mois puis de facon annuelle. Tous ont beneficie d’un examen anatomopathologique sur le cortex reseque. Resultats Sur les 11 enfants, 4 presentaient une encephalite de Rasmussen (36,4 %), 4 autres souffraient d’une hemimegalencephalie (36,4 %), 2 presentaient une dysplasie corticale etendue (18,2 %) enfin un enfant presentait une epilepsie secondaire a un accident vasculaire cerebrale ischemique. Tous les patients ont eu une remission complete postoperatoire immediate des manifestations epileptiques, dont 8 (72,8 %) restent stables pendant le suivi. Pour les autres 3 patients (27,3 %), on a note une re-apparition des crises a distance durant le suivi (18–36 mois postoperatoire). Un patient a ete repris au bloc operatoire pour une deconnexion incomplete, avec une remission totale des crises apres le geste complementaire. Les complications postoperatoires sont centrees sur l’hemiparesie controlaterale, presente chez 100 % des enfants. le deficit predomine a distance sur le membre superieur. Nous n’avons pas enregistre d’hydrocephalies postoperatoires. Deux patients (18,2 %) ont presente une collection sous-durale homolaterale, traitee par une derivation sous-duro-peritoneale, avec une bonne evolution. Ces HSD nous ont conduits a modifier notre technique operatoire. Conclusion L’hemispherotomie verticale para sagittale est un traitement efficace des epilepsies refractaires hemispheriques. Elle permet un controle complet des crises chez la majorite des enfants et une qualite de vie optimale. La recidive de crises a distance doit faire envisager une deconnexion incomplete et envisager un second temps chirurgical. Les HSD peuvent etre eviter par une modification simple de la technique.
- Published
- 2019
15. Épilepsies graves de l’enfant : diagnostic électroclinique et étiologique, principes de prise en charge
- Author
-
M. Milh and N. Villeneuve
- Subjects
business.industry ,Medicine ,business - Published
- 2013
16. Troubles du langage chez les enfants porteurs d’anomalies morphologiques de l’hippocampe
- Author
-
G. Agostini, J. Mancini, B. Chabrol, N. Villeneuve, M. Milh, F. George, B. Maurel B, and N. Girard
- Subjects
Cerebral atrophy ,Pediatrics ,medicine.medical_specialty ,Corpus Callosum Agenesis ,business.industry ,medicine.disease ,Lateralization of brain function ,Epilepsy ,Language assessment ,Pediatrics, Perinatology and Child Health ,medicine ,Autism ,business ,Pathological ,Neuroradiology - Abstract
PURPOSE: Morphologic abnormalities of the hippocampal formations (MAHF) are more frequently observed in magnetic resonance imaging (MRI). We wished to specify the types of disorders associated with these malformations based on a retrospective case series by studying the language of the children presenting these abnormalities. PATIENTS AND METHODS: From the data of all the MRIs taken in the neuroradiology ward of our center over 16 months in patients under 18 years of age, we retrospectively selected the children with an MAHF, isolated or associated with other malformations. The MAHFs were defined and described according to criteria of shape or orientation defects of the hippocampal formations. We studied the files of the patients with isolated MAHF again. Those whose clinical presentation was compatible with language assessment were tested in a prospective approach. RESULTS: Out of 2208 MRIs from 1 January 2007 to 30 April 2008, 96 (4.3%) showed an MAHF, including 61 (64%) boys and 35 (36%) girls, aged from 2 months to 17 years. Eighty-two (85%) had associated abnormalities, mainly including cerebral atrophy, corpus callosum agenesis or defect, and abnormal ventricular frontal horns. Fourteen (15%) had an isolated MAHF: 2 on the left hemisphere, 2 on the right hemisphere, and 10 on both. Of these 14, 9 were compatible with language assessment. From the test results, we divided these children into 2 groups, depending on the type and severity of the impairment. Four had very serious language disorders as part of mental retardation or autistic disorders; 4 others had language disorders predominantly in expression and phonology, with weak to pathological visual memory. This study showed no potential relation between the lateralization of MAHF and language disorders, nor between the existence of epilepsy and the severity of the language disorders. Of these 14 children, 9 had behavior and autism spectrum disorders and 7 were epileptic. CONCLUSION: Even though language disorders are often part of a larger deficiency presentation, the results we obtained suggest that isolated MAHFs are not only causes of amnestic disorders, but they could also directly underlie language disorders, particularly in expression.
- Published
- 2010
17. Desarrollo neurológico
- Author
-
J. Mancini, M. Milh, M.-O. Livet, and B. Chabrol
- Published
- 2009
18. Développement neurologique
- Author
-
J. Mancini, M. Milh, M.-O. Livet, and B. Chabrol
- Published
- 2008
19. [Postinfectious family case of acute necrotizing encephalopathy caused by RANBP2 gene mutation]
- Author
-
C, Di Meglio, A, Cano, M, Milh, N, Girard, L, Burglen, and B, Chabrol
- Subjects
Chromosome Aberrations ,Male ,Neurologic Examination ,Tunisia ,Tegmentum Mesencephali ,Genetic Carrier Screening ,DNA Mutational Analysis ,Mutation, Missense ,Emigrants and Immigrants ,Infant ,Magnetic Resonance Imaging ,Diagnosis, Differential ,Leukoencephalitis, Acute Hemorrhagic ,Nuclear Pore Complex Proteins ,Thalamus ,Virus Diseases ,Cerebellum ,Disease Progression ,Humans ,France ,Dominance, Cerebral ,Genes, Dominant ,Molecular Chaperones - Abstract
Acute necrotizing encephalopathy is a rare neurologic disease most often triggered by a febrile viral event affecting an otherwise healthy infant. The clinical course is characterized by rapid deterioration of the neurological condition that often leads to coma and requires intensive care. The diagnosis is usually suggested by MRI, which shows symmetrical and focal necrotic lesions of thalami. Acute necrotizing encephalopathy has been linked in recent studies to an autosomal-dominant mutation of the gene for the protein RAN-binding protein 2.We report three cases in siblings of Tunisian origin. Two of them presented with acute necrotizing encephalopathy at the age of 9 months in the immediate aftermath of a viral infection. The molecular study conducted in the family showed that both patients and their mother were carriers of the missense mutation gene RAN-binding protein 2.Although the role of Ran BP2 protein is incompletely known, mutation of the RANBP2 gene causes rare, reversible central neurologic disorders. Suspected diagnosis is facilitated by MRI, which shows specific lesions of multifocal, symmetric involvement of the thalami, brainstem tegmentum, supratentorial white matter, and cerebellum. Due to the low frequency of the disease and its non-specific clinical presentation, the diagnosis of acute necrotizing encephalopathy is a major challenge, while preventative measures can be proposed in familial mutation.
- Published
- 2013
20. [Neuromyelitis optica in children. Two case reports]
- Author
-
B, Tosello, C, Halbert, J, Mancini, B, Chabrol, J, Boucraut, M, Milh, Anthropologie bio-culturelle, Droit, Ethique et Santé (ADES), Aix Marseille Université (AMU)-EFS ALPES MEDITERRANEE-Centre National de la Recherche Scientifique (CNRS), Service de Neurologie Pédiatrique, Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Laboratoire d'Enseignement et de Recherche sur le Traitement de l'Information Médicale (LERTIM), Université de la Méditerranée - Aix-Marseille 2, ORL et Chirurgie cervico-faciale pédiatrique - [Hôpitaux Timone et Nord - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)- Hôpital Nord [CHU - APHM], Hôpital de la Timone [CHU - APHM] (TIMONE), Centre de résonance magnétique biologique et médicale (CRMBM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS), and Service de pédiatrie spécialisée et médecine infantile (neurologie, pneumologie, maladies héréditaires du métabolisme) [Hôpital de la Timone - APHM]
- Subjects
Aquaporin 4 ,[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics ,Adolescent ,Murine-Derived/therapeutic use ,Neuromyelitis Optica ,Aquaporin 4/immunology ,Immunologic Factors/therapeutic use ,Antibodies ,Antibodies, Monoclonal, Murine-Derived ,Monoclonal ,Immunologic Factors ,Humans ,Neuromyelitis Optica/*diagnosis/drug therapy ,Female ,Autoantibodies/blood ,Rituximab ,Autoantibodies - Abstract
Place: France; Devic neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system associating acute transverse myelitis and optic neuritis. This is a different disease from multiple sclerosis for which the presence of the NMO antibody directed against aquaporin 4 is a specific marker. Brain damage on MRI does not exclude the diagnosis; the location is superposable in the brain zones rich in aquaporin 4 channels. We report 2 cases of NMO with anti-aquaporin 4. One patient was not symptomatic of brain damage. In this patient, the affinity of anti-NMO for aquaporin 4, studied by flow cytometry, was particularly high. Both patients were treated with immunosuppressive agents (rituximab) due to the failure of or dependence on high-dose corticosteroids.
- Published
- 2012
21. [Assessment of education needs of adolescents and parents of children with epilepsy]
- Author
-
B, Desnous, E, Bourel-Ponchel, E, Raffo, M, Milh, and S, Auvin
- Subjects
Adult ,Male ,Parents ,Health Knowledge, Attitudes, Practice ,Epilepsy ,Adolescent ,Patients ,Brain ,Infant ,Social Behavior Disorders ,Child Behavior Disorders ,Patient Care Management ,Patient Education as Topic ,Seizures ,Child, Preschool ,Health Care Surveys ,Humans ,Anticonvulsants ,Female ,France ,Child ,Life Style ,Needs Assessment - Abstract
Education program for patients (EPP) is now a part of the management of patients with chronic disease. According to WHO, the EPP is designed to help patients to maintain or gain self-care skills and adaptive skills necessary to improve their health and their quality of life. Patient education programs have been developed in recent years in several chronic diseases such as diabetes and asthma. In the field of epilepsy, however, adult and child programs have been developed only recently in France. We evaluate the interests for the establishment of an EPP and the topics that the parents and the adolescents would like to be discussed in such courses.We conducted a qualitative survey, based on interviews of parents of epileptic children and adolescents. The survey was conducted between April and November 2010 in pediatric neurology services of four French university hospitals: Amiens, Nancy, Marseille, and in Robert Debré (Paris) hospital. We investigated the following issues: treatment and self-management, and seizure management, psychosocial difficulties related to epilepsy, anatomical and physiological knowledge of epilepsy and lifestyle.Two topics seem to have the greatest interest for parents of children with epilepsy and adolescents: knowledge about seizures and knowledge of anatomy and physiology of the brain. Adolescents involved in this study gave consistently lower scores in all items compare to parents of children.The medical management of children and adolescents with epilepsy, and their caregivers, is a comprehensive care including the EPP in order to provide a full management of all issues raised by epilepsy. The survey identified key-points that parents and their children would like to learn in an EPP. These data would be helpful to design an EPP.
- Published
- 2011
22. [Epilepsy and mitochondrial diseases: retrospective study on 53 epileptic children]
- Author
-
E, Caietta, A, Cano, C, Halbert, C, Hugonenq, J, Mancini, M, Milh, A, Lépine, N, Villeneuve, A, Chaussenot, V, Paquis-Flucklinger, and B, Chabrol
- Subjects
Male ,Epilepsy ,Mitochondrial Diseases ,Biopsy ,Child, Preschool ,Mutation ,Humans ,Infant ,Female ,Child ,Muscle, Skeletal ,DNA, Mitochondrial ,Retrospective Studies - Abstract
Mitochondrial disease is a heterogeneous disorder entity induced by defects in the mitochondrial respiratory chain complex. Neurological symptoms, including epilepsy, are common in children. The aim of this study was to research the clinical signs indicating mitochondrial disease.We retrospectively studied epileptic children who underwent a muscle and/or hepatic biopsy between 1995 and 2010 searching for a mitochondrial disease. Patients were separated into 2 groups depending on the biopsy result: group 1 (presence of mitochondrial disease) and group 2 (absence of mitochondrial disease). Epileptic phenotypes were compared between these 2 groups. In group 1, we specified the clinical phenotype and characterized mitochondrial disease.Fifty-three children were included: 29 in group 1 and 24 in group 2. The average age at onset of epilepsy was 39.6 months in group 1 versus 11.8 months in group 2. In the 1st group, epilepsy was less refractory and associated with other clinical symptoms.In this study, epilepsy did not appear to be a unique sign of mitochondrial disease. It most often appeared during the 2nd year of life and is correlated with multiorgan involvement, notably ophthalmologic, such as oculomotor apraxia, optic atrophy, and retinitis pigmentosa, as well as auditory (deafness) and hepatic (hepatic failure, hepatomegaly). On the other hand, in children who did not have mitochondrial disease, epilepsy often began earlier (before 3 months of age), it was refractory, isolated without multiorgan involvement, and seems to be due to genetic anomalies in developmental genes, a finding that requires further research.
- Published
- 2011
23. [Association of type 1 diabetes mellitus and epilepsy in children. A cohort of 10 cases]
- Author
-
E, Caietta, C, Halbert, A, Lépine, A, Khammar, A, Cano, M, Gavaret, J, Mancini, N, Villeneuve, B, Chabrol, G, Simonin, R, Reynaud, and M, Milh
- Subjects
Male ,Adolescent ,Glutamate Decarboxylase ,Infant ,Sensitivity and Specificity ,Cohort Studies ,Diagnosis, Differential ,Hospitals, University ,Diabetes Mellitus, Type 1 ,Epilepsy, Temporal Lobe ,Predictive Value of Tests ,Risk Factors ,Child, Preschool ,Humans ,Epilepsy, Generalized ,Female ,Sex Distribution ,Child ,Biomarkers ,Autoantibodies ,Retrospective Studies - Abstract
The association of type 1 diabetes mellitus (DM) and epilepsy has been previously reported. However, the physiopathology of this association remains misunderstood.To describe epilepsy combined with type 1 DM in children.Retrospective monocentric study of all the epileptic and type 1 diabetic children consulting at the Timone University Hospital, Marseille, France. For each patient, the type of epilepsy and its electroclinical and radiographic characteristics were studied as well as the type of diabetes (biological characteristics, glycemic control), and the onset of these 2 diseases.Ten patients are reported. Five suffered from generalized epilepsy (4 idiopathic, 1 nonidiopathic) and 5 from focal epilepsy (4 non-idiopathic, 1 idiopathic). For most of these cases, presence of GAD (glutamic acid decarboxylase) autoantibodies were confirmed and epilepsy followed diabetes.The 2 most common types of epilepsy in this association are idiopathic generalized epilepsy and non-idiopathic temporal epilepsy. Several mechanisms could be involved (immune, glycemia, and genetic disorders).
- Published
- 2010
24. Neuromyelitis optica in France: a multicenter study of 125 patients
- Author
-
B. Fontaine, Bruno Brochet, Giovanni Castelnovo, F. Borgel, Maya Tchikviladzé, David Brassat, Gilles Edan, Nicolas Collongues, M. Milh, P. Tourniaire, Frédéric Blanc, William Camu, Eric Thouvenot, Romain Marignier, Sandrine Wiertlewski, Michel Clanet, J Grimaud, Jean Pelletier, Alain Créange, Marie-Céline Fleury, Marc Debouverie, E. Le Page, Diana Rodriguez, Cyrille B. Confavreux, J. de Seze, Olivier Gout, Olivier Outteryck, Pierre Labauge, Olivier Heinzlef, Caroline Papeix, B. Barroso, David-Axel Laplaud, Bertrand Audoin, Hélène Zéphir, Thibault Moreau, Sandra Vukusic, Gilles-Louis Defer, Christine Lebrun-Frenay, Patrick Vermersch, C. Ritleng, and Aurélie Ruet
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pediatrics ,Adolescent ,Myelitis ,Cohort Studies ,Young Adult ,medicine ,Humans ,Optic neuritis ,Child ,Aged ,Retrospective Studies ,First episode ,Neuromyelitis optica ,Expanded Disability Status Scale ,business.industry ,Neuromyelitis Optica ,Brain ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Prognosis ,Magnetic Resonance Imaging ,Surgery ,Spinal Cord ,Child, Preschool ,Cohort ,Disease Progression ,Female ,Neurology (clinical) ,France ,business ,Cohort study ,Follow-Up Studies - Abstract
Background: There have been few epidemiologic studies on neuromyelitis optica (NMO) and none used the recent 2006 diagnostic criteria. Here we describe the clinical, laboratory, MRI, and disability course of NMO in a French cohort of 125 patients. Methods: We performed an observational, retrospective, multicenter study. Data were collected from September 2007 through August 2008, corresponding to the endpoint of the study. We identified 125 patients fulfilling the 2006 NMO criteria. Selection was made using hospital files and a specific clinical questionnaire for NMO. Results: Mean age at onset was 34.5 years (range 4–66) with a mean disease duration of 10 ± 7.8 years at the endpoint. The patients were mainly (87%) Caucasian, with a female:male ratio of 3:1. In 90% of cases, the association of optic neuritis, longitudinal extensive myelitis, and a Paty-negative initial brain MRI was sufficient to fulfill the supportive criteria. Eighty-eight percent of patients were treated with immunosuppressive therapies. Median delay from onset to Expanded Disability Status Scale (EDSS) score 4 was 7 years; score 6, 10 years; and score 7, 21 years. The first episode of myelitis was immediately followed by an EDSS score ≥4 in 37.3% of cases, and a severe residual visual loss was observed in 22% of patients after the first episode of optic neuritis. Multivariate analysis did not reveal any predictors of a poor evolution other than a high number of MRI brain lesions at diagnosis, which were predictive of a residual visual acuity ≤1/10. Conclusions: Our demographic data provide new data on disability in patients with neuromyelitis optica, most of whom were receiving treatment.
- Published
- 2010
25. [Handicap: definition and classification]
- Author
-
B, Chabrol, C, Halbert, M, Milh, and J, Mancini
- Subjects
Sociology ,Terminology as Topic ,Humans ,Child ,Disabled Children - Published
- 2009
26. [Treatment of childhood convulsive status epilepticus: an update]
- Author
-
M, Milh, N, Villeneuve, and B, Chabrol
- Subjects
Biomedical Research ,Status Epilepticus ,Humans ,Child - Published
- 2009
27. [Language disorders in children with morphologic abnormalities of the hippocampus]
- Author
-
G, Agostini, J, Mancini, B, Chabrol, N, Villeneuve, M, Milh, F, George, B, Maurel, and N, Girard
- Subjects
Male ,Language Disorders ,Adolescent ,Child, Preschool ,Intellectual Disability ,Humans ,Infant ,Female ,Autistic Disorder ,Child ,Hippocampus ,Magnetic Resonance Imaging ,Retrospective Studies - Abstract
Morphologic abnormalities of the hippocampal formations (MAHF) are more frequently observed in magnetic resonance imaging (MRI). We wished to specify the types of disorders associated with these malformations based on a retrospective case series by studying the language of the children presenting these abnormalities.From the data of all the MRIs taken in the neuroradiology ward of our center over 16 months in patients under 18 years of age, we retrospectively selected the children with an MAHF, isolated or associated with other malformations. The MAHFs were defined and described according to criteria of shape or orientation defects of the hippocampal formations. We studied the files of the patients with isolated MAHF again. Those whose clinical presentation was compatible with language assessment were tested in a prospective approach.Out of 2208 MRIs from 1 January 2007 to 30 April 2008, 96 (4.3%) showed an MAHF, including 61 (64%) boys and 35 (36%) girls, aged from 2 months to 17 years. Eighty-two (85%) had associated abnormalities, mainly including cerebral atrophy, corpus callosum agenesis or defect, and abnormal ventricular frontal horns. Fourteen (15%) had an isolated MAHF: 2 on the left hemisphere, 2 on the right hemisphere, and 10 on both. Of these 14, 9 were compatible with language assessment. From the test results, we divided these children into 2 groups, depending on the type and severity of the impairment. Four had very serious language disorders as part of mental retardation or autistic disorders; 4 others had language disorders predominantly in expression and phonology, with weak to pathological visual memory. This study showed no potential relation between the lateralization of MAHF and language disorders, nor between the existence of epilepsy and the severity of the language disorders. Of these 14 children, 9 had behavior and autism spectrum disorders and 7 were epileptic.Even though language disorders are often part of a larger deficiency presentation, the results we obtained suggest that isolated MAHFs are not only causes of amnestic disorders, but they could also directly underlie language disorders, particularly in expression.
- Published
- 2009
28. TRANSPORTERS | Function of Cell-Surface Glutamate Transporters in the Brain: An Important Role for Development and Preventing Seizures
- Author
-
Alfonso Represa, N. Villeneuve, M. Milh, Laurent Aniksztejn, and Adriano Augusto Cattani
- Subjects
Epilepsy ,medicine.anatomical_structure ,Metabotropic glutamate receptor ,Neurogenesis ,Central nervous system ,medicine ,Glutamate receptor ,NMDA receptor ,Neurotoxin ,Biology ,medicine.disease ,Neuroscience ,Epileptogenesis - Abstract
Glutamate is the main excitatory transmitter in the central nervous system. It plays major roles in the development of the brain, including neurogenesis, migration, and synapse formation. It is also involved in many aspects of normal brain function, including learning and memory. However, glutamate acts also as a powerful neurotoxin and is involved in many neurodegenerative diseases and disorders of uncontrolled excitability – such as epilepsy. The physiological or pathological function of glutamate is, in part, determined by its spatiotemporal concentration profile in the extracellular space, which is in turn controlled by the neuronal and the glial cell-surface membrane glutamate transporters (GluTs). The primary function of these transporters is to uptake and transport glutamate from the extracellular to the intracellular space, where glutamate may be used for neurotransmission or metabolic needs. This article focuses on the main function of the GluTs in the central nervous system, and their key role during development for the control of cortical network activity and the prevention of epileptic seizures.
- Published
- 2009
29. [GLUT-1 deficiency syndrome or De Vivo disease: a case report]
- Author
-
I, Ticus, A, Cano, N, Villeneuve, M, Milh, J, Mancini, and B, Chabrol
- Subjects
Blood Glucose ,Male ,Glucose Transporter Type 1 ,Heterozygote ,Epilepsy ,Infant ,Syndrome ,Glucose ,Blood-Brain Barrier ,Mutation ,Microcephaly ,Humans ,Muscle Hypotonia ,Ataxia ,Carbohydrate Metabolism, Inborn Errors - Abstract
GLUT-1 protein is the principal glucose transporter across the blood-brain barrier. GLUT-1 deficiency results in a syndrome of infantile seizures refractory to anticonvulsive drugs, developmental delay, acquired microcephaly and neurologic manifestations including spasticity, hypotonia, and ataxia. A low cerebrospinal fluid glucose concentration in the absence of hypoglycaemia is pathognomonic of glucose transporter deficiency syndrome. Ketogenic diet is an effective treatment of epileptic manifestations but it has less effect on the cognitive symptoms. We report on a child who presented with paroxistical events often occurring prior to meals, developmental delay, microcephaly and spasticity. CSF and serum glucose levels measured simultaneously showed a CSF/serum glucose ratio of 0.39. Molecular analysis identified a heterozygous novel mutation.
- Published
- 2007
30. [Epileptic seizures in childhood: from seizure type to diagnosis]
- Author
-
M, Milh, I, Ticus, N, Villeneuve, C, Hugonencq, J, Mancini, and B, Chabrol
- Subjects
Epilepsy ,Adolescent ,Myoclonic Epilepsy, Juvenile ,Age Factors ,Infant, Newborn ,Infant ,Electroencephalography ,Magnetic Resonance Imaging ,Vigabatrin ,Diagnosis, Differential ,Epilepsy, Absence ,Seizures ,Humans ,Anticonvulsants ,Epilepsies, Partial ,Child ,Spasms, Infantile - Abstract
Epileptic seizures can be difficult to recognize in infancy and childhood because the semeiology can be misleading. Already, in the acute phase, precise assessment of the seizure is required, with active questioning about circumstances of occurrence, clinical manifestations and postictal symptoms. Laboratory tests and toxicologic screening should only be performed according to the circumstances and clinical examination in order to distinguish between symptomatic seizure and epilepsy at the beginning. Epilepsy consists in repetition of several unprovoked epileptic seizure. Assessment of the age of onset, type of seizures, interictal EEG and the neuropsychological profile are instrumental for both the diagnosis of epileptic syndrome and the choice of the right treatment. Epileptic seizures cause distress to parents and the fear they experience of death must always be taken into account.
- Published
- 2007
31. Déconnexions sus-insulaires de la zone épileptogène (ze) guidée par SEEG : une alternative vraiment fonctionnelle à l’hémisphérotomie en présence d’une épilepsie réfractaire post-AVC sylvien étendu chez l’enfant
- Author
-
Fabrice Bartolomei, Nadine Girard, Nathalie Villeneuve, Didier Scavarda, Agnès Trébuchon, M. Milh, Anne Lépine, and G. Pech-Gourg
- Subjects
Surgery ,Neurology (clinical) - Abstract
Introduction Une crise d’epilepsie est un signe frequent inaugural d’un accident vasculaire cerebral chez l’enfant. Vingt-cinq pour cent de ces enfants vont presenter une epilepsie. La frequence de l’epilepsie refractaire varie de 0 a 6O % dans la litterature. L’hemispherotomie fonctionnelle est actuellement le « gold standard » lors de la prise en charge neurochirurgicale. Nous rapportons pour la premiere fois notre experience de deconnexion sus-insulaire guidee par SEEG des aires « centrales » chez ces enfants. Materiels et methode Suivi prospectif. 2 enfants de 12 et 13 ans. Epilepsie refractaire evoluant depuis 6 ans pour l’un et 5 ans pour l’autre suite a un AVC ischemique sylvien etendu, de cause inconnue malgre un bilan exhaustif. Un bilan complet pre chirurgical a ete realise associant, EEG, video–EEG, champ visuel, Pet TDM, IRM morphologique et fonctionnelle ainsi qu’un bilan neuropsychologique. La frequence des crises est variable, pluri quotidiennes chez la fille et pluri-hebdomadaires pour le garcon. Les chutes sont frequentes avec presence de traumatismes violents retrouves dans l’historique. Une SEEG sans cadre controlee par la neuronavigation a ete realisee chez les 2 enfants dans l’idee de realiser une deconnexion fonctionnelle epargnant les regions non epileptogenes. Resultats Pour ces 2 enfants, la SEEG a permis de visualiser plusieurs crises habituelles. La zone ZE a pu etre delimitee par correlations electro-cliniques et confirmee par le calcul de l’index d’epileptogenicite sur les differentes electrodes impliquees. La ZE etait a chaque fois centree par le foyer ischemique et entourait le sillon central. Nous avons implante 11 electrodes chez le garcon et 12 chez la fille. Il n’y avait aucun argument pour une ZE temporale ou occipitale associee. Le bilan neuropsychologique restait dans la normale faible. Une deconnexion sus insulaire de la ZE a ete realisee. Les 2 enfants sont classes actuellement Engel 1 avec un suivi moyen de 11 mois. L’hemiplegie post-operatoire a recupere en 3 semaines. Les 2 enfants ont ameliore leur autonomie et ont repris une scolarisation normale avec AVS. La diminution des traitements oraux a ete debutee. Conclusion La deconnexion sus insulaire guidee par SEEG de la ZE permet une deconnexion respectant au mieux les regions saines et les grands faisceaux de substance blanche. Elle nous parait representer une veritable alternative fonctionnelle a l’hemispherotomie chez ces enfants. La preservation des structures occipitales et temporales doit ameliorer la qualite de vie de ces enfants et probablement leurs resultats scolaires. L’etude SEEG est un imperatif dans la prise de decision. Nous rapportons les 2 premiers cas de deconnexion sus insulaire de la ZE chez des enfants presentant une epilepsie refractaire apres AVC ischemique sylvien large. Ces resultats doivent etre confirmes a l’avenir.
- Published
- 2014
32. Éverolimus chez des patients atteints d’astrocytomes sous épendymaires à cellules géantes (SEGA) associés à une sclérose tubéreuse de Bourneville (STB) en France : résultats préliminaires. Étude européenne Effects
- Author
-
J.-M. Pedespan, A. De Saint Martin, F. Audic-Gerard, C. Cances, P. Chastagner, M. Milh, S. Nguyen The Tich, A. Riquet, L. Vallée, F. Fardao-Beyler, and R. Nabbout
- Subjects
Pediatrics, Perinatology and Child Health - Published
- 2013
33. P1098: Auditory evoked temporal 'delta brushes' in human premature neonates
- Author
-
Mathilde Chipaux, R. Khazipov, Anna Kaminska, M. Colonnese, C. Chiron, M. Mokhtari, M. Milh, Olivier Dulac, and A. Mauguen
- Subjects
Delta ,medicine.medical_specialty ,Neurology ,business.industry ,Physiology (medical) ,Medicine ,Neurology (clinical) ,Audiology ,business ,Sensory Systems - Published
- 2014
34. Impact de la chirurgie de l’épilepsie sur le devenir cognitif et le contrôle des crises chez 51 enfants et adolescents suivis sur une période de 1 à 5ans après l’intervention
- Author
-
J. Regis, Agnès Trébuchon, Jean-Claude Peragut, Anne Lépine, Patrick Chauvel, Fabrice Bartolomei, Nathalie Villeneuve, Didier Scavarda, B. Chabrol, Gabriel Lena, V. Laguitton, and M. Milh
- Subjects
Surgery ,Neurology (clinical) - Published
- 2013
35. Évaluation d’une méthodologie simplifiée d’implantation d’électrodes profondes d’enregistrement de l’EEG (SEEG), assistée par ordinateur, sans cadre et avec un bras à biopsie non robotisé chez des enfants présentant une épilepsie réfractaire : bilan de la première année d’utilisation
- Author
-
Gabriel Lena, Agnès Trébuchon, H Peyriere, Fabrice Bartolomei, N. Villeneuve, M. Milh, G. Pech-Gourg, Maxime Guye, Didier Scavarda, and Nadine Girard
- Subjects
Surgery ,Neurology (clinical) - Published
- 2012
36. Implantations d’électrodes profondes d’enregistrement de l’EEG chez les enfants présentant une épilepsie réfractaire avec une méthodologie simplifiée, sans cadre, avec un bras à biopsie non robotisé et assistée par ordinateur : résultats préliminaires
- Author
-
Nadine Girard, Fabrice Bartolomei, M. Milh, Gabriel Lena, Didier Scavarda, N. Villeneuve, and G. Pech-Gourg
- Subjects
Surgery ,Neurology (clinical) - Published
- 2011
37. W16.3 A developmental switch in sensory processing prepares premature neocortex for vision
- Author
-
Anna Kaminska, R. Khazipov, M. Milh, M. Colonnese, M. Chipaux, and C. Chiron
- Subjects
Neocortex ,medicine.anatomical_structure ,Neurology ,Sensory processing ,Physiology (medical) ,medicine.medical_treatment ,medicine ,Neurology (clinical) ,Psychology ,Neuroscience ,Sensory Systems - Published
- 2011
38. P169 - Neurones
- Author
-
M. Milh, S. Feldt, A. Lepine, and R. Cossart
- Subjects
Pediatrics, Perinatology and Child Health - Published
- 2010
39. Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders.
- Author
-
Cali E, Quirin T, Rocca C, Efthymiou S, Riva A, Marafi D, Zaki MS, Suri M, Dominguez R, Elbendary HM, Alavi S, Abdel-Hamid MS, Morsy H, Mau-Them FT, Nizon M, Tesner P, Ryba L, Zafar F, Rana N, Saadi NW, Firoozfar Z, Gencpinar P, Unay B, Ustun C, Bruel AL, Coubes C, Stefanich J, Sezer O, Agolini E, Novelli A, Vasco G, Lettori D, Milh M, Villard L, Zeidler S, Opperman H, Strehlow V, Issa MY, El Khassab H, Chand P, Ibrahim S, Nejad-Rashidi A, Miryounesi M, Larki P, Morrison J, Cristian I, Thiffault I, Bertsch NL, Noh GJ, Pappas J, Moran E, Marinakis NM, Traeger-Synodinos J, Hosseini S, Abbaszadegan MR, Caumes R, Vissers LELM, Neshatdoust M, Montazer MZ, El Fahime E, Canavati C, Kamal L, Kanaan M, Askander O, Voinova V, Levchenko O, Haider S, Halbach SS, Maia ER, Mansoor S, Vivek J, Tawde S, Santhosh R Challa V, Gowda VK, Srinivasan VM, Victor LA, Pinero-Banos B, Hague J, Ei-Awady HA, Maria de Miranda Henriques-Souza A, Cheema HA, Anjum MN, Idkaidak S, Alqarajeh F, Atawneh O, Mor-Shaked H, Harel T, Zifarelli G, Bauer P, Kok F, Kitajima JP, Monteiro F, Josahkian J, Lesca G, Chatron N, Ville D, Murphy D, Neul JL, Mullegama SV, Begtrup A, Herman I, Mitani T, Posey JE, Tay CG, Javed I, Carr L, Kanani F, Beecroft F, Hane L, Abdelkreem E, Macek M, Bispo L, Elmaksoud MA, Hashemi-Gorji F, Pehlivan D, Amor DJ, Jamra RA, Chung WK, Ghayoor EK, Campeau P, Alkuraya FS, Pagnamenta AT, Gleeson J, Lupski JR, Striano P, Moreno-De-Luca A, Lafontaine DLJ, Houlden H, and Maroofian R
- Abstract
Purpose: This study aims to comprehensively delineate the phenotypic spectrum of ACTL6B-related disorders, previously associated with both autosomal recessive and autosomal dominant neurodevelopmental disorders. Molecularly, the role of the nucleolar protein ACTL6B in contributing to the disease has remained unclear., Methods: We identified 105 affected individuals, including 39 previously reported cases, and systematically analysed detailed clinical and genetic data for all individuals. Additionally, we conducted knockdown experiments in neuronal cells to investigate the role of ACTL6B in ribosome biogenesis., Results: Biallelic variants in ACTL6B are associated with severe-to-profound global developmental delay/intellectual disability (GDD/ID), infantile intractable seizures, absent speech, autistic features, dystonia, and increased lethality. De novo monoallelic variants result in moderate-to-severe GDD/ID, absent speech, and autistic features, while seizures and dystonia were less frequently observed. Dysmorphic facial features and brain abnormalities, including hypoplastic corpus callosum, parenchymal volume loss/atrophy, are common findings in both groups. We reveal that in the nucleolus, ACTL6B plays a crucial role in ribosome biogenesis, in particular in pre-rRNA processing., Conclusion: This study provides a comprehensive characterization of the clinical spectrum of both autosomal recessive and dominant forms of ACTL6B-associated disorders. It offers a comparative analysis of their respective phenotypes provides a plausible molecular explanation and suggests their inclusion within the expanding category of 'ribosomopathies'., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
40. Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants.
- Author
-
Mohammadi NA, Ahring PK, Yu Liao VW, Chua HC, Ortiz de la Rosa S, Johannesen KM, Michaeli-Yossef Y, Vincent-Devulder A, Meridda C, Bruel AL, Rossi A, Patel C, Klepper J, Bonanni P, Minghetti S, Trivisano M, Specchio N, Amor D, Auvin S, Baer S, Meyer P, Milh M, Salpietro V, Maroofian R, Lemke JR, Weckhuysen S, Christophersen P, Rubboli G, Chebib M, Jensen AA, Absalom NL, and Møller RS
- Subjects
- Humans, Male, Female, Child, Child, Preschool, Gain of Function Mutation, Loss of Function Mutation, Neurodevelopmental Disorders genetics, Genetic Predisposition to Disease, Adolescent, Infant, Adult, Genotype, Alleles, Receptors, GABA-A genetics, Phenotype, Genetic Association Studies, Epilepsy genetics
- Abstract
Background: Variants in GABRB2, encoding the β2 subunit of the γ-aminobutyric acid type A (GABA
A ) receptor, can result in a diverse range of conditions, ranging from febrile seizures to severe developmental and epileptic encephalopathies. However, the mechanisms underlying the risk of developing milder vs more severe forms of disorder remain unclear. In this study, we conducted a comprehensive genotype-phenotype correlation analysis in a cohort of individuals with GABRB2 variants., Methods: Genetic and electroclinical data of 42 individuals harbouring 26 different GABRB2 variants were collected and accompanied by electrophysiological analysis of the effects of the variants on receptor function., Findings: Electrophysiological assessments of α1β2γ2 receptors revealed that 25/26 variants caused dysfunction to core receptor properties such as GABA sensitivity. Of these, 17 resulted in gain-of-function (GOF) while eight yielded loss-of-function traits (LOF). Genotype-phenotype correlation analysis revealed that individuals harbouring GOF variants suffered from severe developmental delay/intellectual disability (DD/ID, 74%), movement disorders such as dystonia or dyskinesia (59%), microcephaly (50%) and high risk of early mortality (26%). Conversely, LOF variants were associated with milder disease manifestations. Individuals with these variants typically exhibited fever-triggered seizures (92%), milder degrees of DD/ID (85%), and maintained ambulatory function (85%). Notably, severe movement disorders or microcephaly were not reported in individuals with loss-of-function variants., Interpretation: The data reveals that genetic variants in GABRB2 can lead to both gain and loss-of-function, and this divergence is correlated with distinct disease manifestations. Utilising this information, we constructed a diagnostic flowchart that aids in predicting the pathogenicity of recently identified variants by considering clinical phenotypes., Funding: This work was funded by the Australian National Health & Medical Research Council, the Novo Nordisk Foundation and The Lundbeck Foundation., Competing Interests: Declaration of interests SOR is the chair of the Young Epilepsy Section, ILAE, and has received consulting fees from Biopas-UCB, support for attending meetings and/or travel from Mythotherapies, and speaker fees from Abbott, LivaNova, Sanofi, Biopas-UCB and Nutricia. MT has received consulting fees from Biomarin, support for attending meetings and/or travel from Biomarin and Jazz Pharmaceuticals, and participated in Data Safety Monitoring Boards or Advisory Boards for Biocodex. SA is the deputy editor of Epilepsia, and has received consulting fees from UCB, Xenon, Encoded Therapeutics, EISAI, Stoke, Proveca, speaker fees from Biocodex, EISAI, Jazz Pharmaceuticals, Neuraxpharm, Nutricia and UCB and participated in Data Safety Monitoring Boards or Advisory Boards for GRIN Therapeutics. JK has received consulting fees from Biomarin, support for attending meetings and/or travel from Biomarin and Jazz Pharmaceuticals, and participated in Data Safety Monitoring Boards or Advisory Boards for Biocodex. SW has received consulting fees from UCB, Knopp Biosciences, Encoded Therapeutics, Roche, support for attending meetings and/or travel from Angelini Pharma, and participated in Data Safety Monitoring Boards or Advisory Boards for Angelini Pharma and Xenon Pharmaceuticals. NS has received consulting fees from Biomarin, support for attending meetings and/or travel from Biomarin and Jazz Pharmaceuticals, and participated in Data Safety Monitoring Boards or Advisory Boards for Biocodex. PB has received consulting fees from LivaNova, EISAI, Jazz Pharmaceuticals, Angelini Pharma and support for attending meetings and/or travel from Angelini Pharma and EISAI. RSM has received consulting fees from UCB, Orion, Saniona, Immedica and Atalanta, and speaker fees from EISAI, Angelini Pharma, Jazz Pharmaceuticals, Orion and UCB. PC is Executive Vice President, Research at the company Saniona in Denmark. The remaining authors declare no competing interests., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
41. Pathways to epilepsy surgery in children with tuberous sclerosis complex-associated epilepsy.
- Author
-
Gauer L, Lagarde S, Valenti-Hirsch MP, Makhalova J, Milh M, Baer S, Lepine A, Ollivier I, Scavarda D, Hirsch E, Bartolomei F, De Saint-Martin A, and Villeneuve N
- Abstract
Background: Previous studies showed the efficacy of epilepsy surgery in carefully selected children with epilepsy associated with tuberous sclerosis complex. However, how this selection is conducted, and the characteristics of the patients brought to surgery are still poorly described. By conducting a multicentric retrospective cohort study covering the practice of the last twenty years, we describe the paths leading to epilepsy surgery in children with epilepsy associated with tuberous sclerosis complex., Methods: We identified 84 children diagnosed with tuberous sclerosis complex and epilepsy by matching two exhaustive registries of genetic diseases and subsequent medical records reviews within two French neuropediatric and epilepsy centers. Demographic, clinical, longitudinal, and diagnostic and surgical procedures data were collected., Results: Forty-six percent of the children were initially drug-resistant and 19% underwent resective surgery, most often before the age of four. Stereotactic electroencephalography was performed prior to surgery in 44% of cases. Fifty-seven and 43% of patients remained seizure-free one and ten years after surgery, respectively. In addition, 52% of initially drug-resistant patients who did not undergo surgery were seizure-free at the last follow-up. The number of anti-seizure medications required decreased in 50% of cases after surgery. Infantile spasms, intellectual disability, autism spectrum disorder or severe behavioral disorders were not contraindications to surgery but were associated with a higher rate of complications and a lower rate of seizure freedom after surgery., Conclusion: Despite the assumption of complex multifocal epilepsy and practical difficulties in young children with tuberous sclerosis complex, successful surgery results are comparable with other populations of patients with drug-resistant epilepsy, and a spontaneous evolution to drug-sensitive epilepsy may occur in non-operated patients., (Copyright © 2024 Elsevier Masson SAS. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
42. Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.
- Author
-
Rheims S, Herbillon V, Gaillard S, Mercier C, Villeuve N, Villéga F, Cances C, Castelnau P, Napuri S, de Saint-Martin A, Auvin S, Nguyen The Tich S, Berquin P, de Bellecize J, Milh M, Roy P, Arzimanoglou A, Bodennec J, Bezin L, and Kassai B
- Subjects
- Child, Humans, Adolescent, Phosphatidylserines therapeutic use, Treatment Outcome, Fatty Acids, Unsaturated therapeutic use, Dietary Supplements, Attention Deficit Disorder with Hyperactivity complications, Attention Deficit Disorder with Hyperactivity drug therapy, Fatty Acids, Omega-3 therapeutic use, Epilepsy drug therapy
- Abstract
Background: Attention-deficit hyperactivity disorder (ADHD) is a frequent comorbidity in children with epilepsy, which management mostly relies on the usual treatments of ADHD, especially methylphenidate. Supplementation with polyunsaturated n-3 Fatty Acid (PUFA) has been proposed as an alternative therapeutic approach in ADHD without epilepsy but has never been evaluated in epilepsy-associated ADHD., Methods: A multicenter double blind randomized placebo-controlled trial evaluating supplementation with PUFA, in eicosapentaenoic- and docosahexaenoic-acid form, conjugated to a phospholipid vector (PS-Omega3) in children aged >6 and <16-years old, and suffering from any type of epilepsy and ADHD (inattentive or combined type) according to DSM-V. After a 4-week baseline period, patients were allocated (1:1) either to placebo group or to PS-Omega 3 group and entered a 12 week-double-blind treatment period which was followed by a 12 week-open-label treatment period. The primary outcome was the reduction of the ADHD-rating scale IV attention-deficit subscore after 12 weeks of treatment., Results: The study was stopped early because of lack of eligible participants and the expected sample size was not reached. Seventy-four patients were randomized, 44 in PS-Omega3, and 30 in the placebo group. The reduction after 12 weeks of treatment in the inattention subscore of the ADHD-IV scale was -1.57 in the PS-Omega3 group, and -2.90 in the placebo group (p = 0.33, α = 5%). Results were similar after 24 weeks of treatment and for all other ADHD-related secondary outcomes, with no difference between placebo and PS-Omega3., Conclusion: Our study remaining underpowered, no formal conclusion about the effect of Ps-Omega3 could be drawn. However, our data strongly suggested that the PS-Omega 3 formulation used in the current study did not improve ADHD symptoms in children with epilepsy., Plain Language Summary: Supplementation with polyunsaturated n-3 Fatty Acid (PUFA) has been proposed in ADHD but has never been evaluated in patients with both epilepsy and ADHD. To address this issue, we conducted a multicenter double blind randomized placebo-controlled trial evaluating supplementation with PUFA in children with epilepsy and ADHD. The study was stopped early because of lack of eligible participants, hampering formal conclusion. However, the evolution of the ADHD symptoms at 12 and 24 weeks did not differ between placebo and PUFA supplementation, strongly suggesting that PUFA did not improve ADHD symptoms in children with epilepsy., (© 2024 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.)
- Published
- 2024
- Full Text
- View/download PDF
43. Diffuse interstitial lung disease in a male fetus with periventricular nodular heterotopia and filamin A mosaic variant.
- Author
-
Desnous B, Carles G, Riccardi F, Stremler N, Baravalle M, El-Louali F, Testud B, and Milh M
- Subjects
- Infant, Humans, Male, Female, Pregnancy, Young Adult, Adult, Filamins genetics, Mutation, Magnetic Resonance Imaging, Periventricular Nodular Heterotopia diagnostic imaging, Periventricular Nodular Heterotopia genetics, Epilepsy genetics, Lung Diseases, Interstitial
- Abstract
Background: Most periventricular nodular heterotopias (PNHs) are associated with a mutation in the filamin A (FLNA) gene in Xq28. This condition is associated with cardiovascular malformations, connective tissue abnormalities, epilepsy, and intellectual deficiency of varying severity., Materials and Methods: We report a new FLNA gene mutation in a male patient associated with PNH and diffuse interstitial lung disease., Results: A 23-year-old woman was referred at 31 gestational weeks to evaluate a suspected mega cisterna magna and ventricular septal defect with atrioventricular valve alignment in a male fetus. The fetal magnetic resonance imaging showed PNH associated with corpus callosum dysgenesis and a mega cisterna magna. At 2 months of age, the infant was diagnosed with severe respiratory distress with hypoxemia. A chest CT scan demonstrated a diffuse interstitial lung pattern with emphysema, multiple atelectasis foci, and signs of pulmonary hypertension. Rapid worsening led to his death at 4 months. Targeted sequencing of the FLNA gene identified a de novo hemizygous variant in 75% mosaic in lymphocyte cells, resulting in incomplete FLNA function loss., Discussion & Conclusion: On the diagnosis of antenatal PNH, the possibility of such lung involvement should be considered in the prognostic evaluation during prenatal counseling., (© 2023 John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
44. Loss of NDST1 N-sulfotransferase activity is associated with autosomal recessive intellectual disability.
- Author
-
Khosrowabadi E, Mignon-Ravix C, Riccardi F, Cacciagli P, Desnous B, Sigaudy S, Milh M, Villard L, Kjellén L, and Molinari F
- Subjects
- Humans, Acetylglucosamine, Cognition, Inheritance Patterns, Mutant Proteins, Sulfotransferases genetics, Intellectual Disability genetics
- Abstract
Intellectual Disability (ID) is the major cause of handicap, affecting nearly 3% of the general population, and is highly genetically heterogenous with more than a thousand genes involved. Exome sequencing performed in two independent families identified the same missense variant, p.(Gly611Ser), in the NDST1 (N-deacetylase/N-sulfotransferase member 1) gene. This variant had been previously found in ID patients of two other families but has never been functionally characterized. The NDST1 gene encodes a bifunctional enzyme that catalyzes both N-deacetylation and N-sulfation of N-acetyl-glucosamine residues during heparan sulfate (HS) biosynthesis. This step is essential because it influences the downstream enzymatic modifications and thereby determines the overall structure and sulfation degree of the HS polysaccharide chain. To discriminate between a rare polymorphism and a pathogenic variant, we compared the enzymatic properties of wild-type and mutant NDST1 proteins. We found that the p.(Gly611Ser) variant results in a complete loss of N-sulfotransferase activity while the N-deacetylase activity is retained. NDST1 shows the highest and the most homogeneous expression in the human cerebral structures compared to the other members of the NDST gene family. These results indicate that a loss of NDST1 N-sulfation activity is associated with impaired cognitive functions., (© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
45. Familial KCNQ2 mutation: a psychiatric perspective.
- Author
-
Iftimovici A, Charmet A, Desnous B, Ory A, Delorme R, Coutton C, Devillard F, Milh M, and Maruani A
- Subjects
- Male, Humans, Child, Preschool, Mutation genetics, Exons, KCNQ2 Potassium Channel genetics, Seizures genetics
- Abstract
KCNQ2 mutations are a common cause of early-onset epileptic syndromes. They are associated with heterogeneous developmental profiles, from mild to severe cognitive and social impairments that need better characterization. We report a case of an inherited KCNQ2 mutation due to a deletion c.402delC in a heterozygous state, in the exon 3 of the KCNQ2 gene. A 5-year-old boy presented a cluster of sudden-onset generalized tonic-clonic seizures at three months of age, after an unremarkable postnatal period. Multiplex ligation-dependent probe amplification identified a familial mutation after an investigation in the family revealed that this mutation was present on the father's side. The patient was diagnosed with autism and intellectual deficiency in a context of KCNQ2 -encephalopathy. We describe his clinical features in light of current literature. This report highlights the importance of appropriate genetic counseling and psychiatric assessment in planning the medical and social follow-up of a disorder with complex socio-behavioral features., (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
46. Efficacy and tolerance of cannabidiol in the treatment of epilepsy in patients with Rett syndrome.
- Author
-
Desnous B, Beretti T, Muller N, Neveu J, Villeneuve N, Lépine A, Daquin G, and Milh M
- Subjects
- Humans, Clobazam therapeutic use, Anticonvulsants, Seizures drug therapy, Seizures etiology, Cannabidiol therapeutic use, Rett Syndrome complications, Rett Syndrome drug therapy, Rett Syndrome chemically induced, Epilepsy drug therapy
- Abstract
We aim to assess the efficacy and tolerance of cannabidiol as adjunctive therapy for Rett syndrome (RTT) patients with epilepsy. We conducted a longitudinal observational study through a monocentric cohort of 46 patients with RTT. Patients were recruited from March 2020 to October 2022 and were treated with Epidyolex® (cannabidiol, CBD, 100 mg/mL oral solution). In our cohort, 26 patients had associated epilepsy (26/46 [56%]), and 10/26 (38%) were treated with CBD, in combination with clobazam in 50% of cases. The median dose at their last follow-up was 15 mg/kg/day. The median treatment duration was 13 months (range: 1-32 months). CBD reduced the incidence of seizures in seven out of 10 patients (70%) with one seizure-free patient, two patients with a reduction of seizures of more than 75%, and four patients with a decrease of more than 50%. No aggravation of symptoms or adverse effects were observed. Only one patient experienced a transitory drooling and somnolence episode at the CBD initiation. Half of the patients showed a reduction in agitation and/or anxiety attacks, and an improvement in spasticity was reported in 4/10 (40%) of patients. CBD appears to have potential therapeutic value for the treatment of drug-resistant epilepsy in Rett syndrome. CBD is well tolerated and, when used in combination with clobazam, may increase the effectiveness of clobazam alone., (© 2023 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.)
- Published
- 2024
- Full Text
- View/download PDF
47. Parents' experiences of parenting a child with profound intellectual and multiple disabilities in France: A qualitative study.
- Author
-
Aim MA, Rousseau MC, Hamouda I, Anzola AB, de Villemeur TB, Milh M, Maincent K, Lind K, Auquier P, Baumstarck K, and Dany L
- Subjects
- Humans, France, Female, Male, Child, Adult, Adolescent, Interviews as Topic, Young Adult, Disabled Children psychology, Parents psychology, Qualitative Research, Parenting psychology, Intellectual Disability psychology
- Abstract
Introduction: Parents of persons with profound intellectual and multiple disabilities (PIMD) play a major and often lifelong role in the care and support of their child. A better understanding of parents' perspectives regarding their experiences of parenting their child with PIMD is essential to support them more effectively. Although this topic has been explored extensively in Anglo-Saxon and Northern European countries, little is known about the experience of these parents in a highly institutionalized context such as that in France., Objective: We explored parents' experiences of the activities they performed to care for their child with PIMD (namely, the 'parenting work') in the French context., Method: Qualitative semistructured interviews were conducted by telephone with 34 parents of persons with PIMD aged 8-35. The resulting data were analyzed using thematic analysis., Results: The analysis highlighted the diversity of activities performed by parents as well as the influence of context on the forms of this parenting work. Five themes were developed: (1) navigating the challenges of obtaining medical recognition; (2) negotiating a concealed domain and becoming an expert; (3) unfolding medical and medicosocial care management; (4) navigating the challenges of daily living and (5) shaping one's child's possibilities., Conclusion: This study offers a better understanding of the challenges, levers and expectations of parents of children with PIMD in France. Contextual factors such as the lack of knowledge of PIMD among health professionals, access to knowledge and know-how associated with care management, the administrative complexity of access to care and equipment, institutional issues (e.g., professional turnover) and societal ableism (e.g., access to infrastructures, interpersonal discrimination) shape the work parents perform to support their child's needs. It is necessary to consider contextual aspects to better support these parents and their children. Suggestions for applications are provided in the discussion., Patient or Public Contribution: One of the researchers, a parent of a child with PIMD, supported the research design and provided feedback on the study's procedures and manuscript., (© 2023 The Authors. Health Expectations published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
48. Further characterisation of ARX -related disorders in females due to inherited or de novo variants.
- Author
-
Gras M, Heide S, Keren B, Valence S, Garel C, Whalen S, Jansen AC, Keymolen K, Stouffs K, Jennesson M, Poirsier C, Lesca G, Depienne C, Nava C, Rastetter A, Curie A, Cuisset L, Des Portes V, Milh M, Charles P, Mignot C, and Héron D
- Subjects
- Male, Humans, Female, Genes, Homeobox, Homeodomain Proteins genetics, Mutation genetics, Transcription Factors genetics, Phenotype, Agenesis of Corpus Callosum genetics, Autism Spectrum Disorder genetics, Intellectual Disability genetics, Intellectual Disability pathology
- Abstract
The Aristaless-related homeobox ( ARX ) gene is located on the X chromosome and encodes a transcription factor that is essential for brain development. While the clinical spectrum of ARX -related disorders is well described in males, from X linked lissencephaly with abnormal genitalia syndrome to syndromic and non-syndromic intellectual disability (ID), its phenotypic delineation in females is incomplete. Carrier females in ARX families are usually asymptomatic, but ID has been reported in some of them, as well as in others with de novo variants. In this study, we collected the clinical and molecular data of 10 unpublished female patients with de novo ARX pathogenic variants and reviewed the data of 63 females from the literature with either de novo variants (n=10), inherited variants (n=33) or variants of unknown inheritance (n=20). Altogether, the clinical spectrum of females with heterozygous pathogenic ARX variants is broad: 42.5% are asymptomatic, 16.4% have isolated agenesis of the corpus callosum (ACC) or mild symptoms (learning disabilities, autism spectrum disorder, drug-responsive epilepsy) without ID, whereas 41% present with a severe phenotype (ie, ID or developmental and epileptic encephalopathy (DEE)). The ID/DEE phenotype was significantly more prevalent in females carrying de novo variants (75%, n=15/20) versus in those carrying inherited variants (27.3%, n=9/33). ACC was observed in 66.7% (n=24/36) of females who underwent a brain MRI. By refining the clinical spectrum of females carrying ARX pathogenic variants, we show that ID is a frequent sign in females with this X linked condition., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
49. Real-life data comparing the efficacy of vigabatrin and oral steroids given sequentially or combined for infantile epileptic spasms syndrome.
- Author
-
Dozieres-Puyravel B, Nasser H, Mauvais FX, De Saint Martin A, Perriard C, Di Meglio C, Cances C, Hachon-LE Camus C, Milh M, and Auvin S
- Subjects
- Infant, Humans, Anticonvulsants therapeutic use, Retrospective Studies, Prospective Studies, Steroids therapeutic use, Syndrome, Spasm, Treatment Outcome, Vigabatrin therapeutic use, Spasms, Infantile drug therapy, Spasms, Infantile etiology
- Abstract
Aims: The prognosis of Infantile epileptic spasm syndrome (IESS), relates to the underlying etiology and delay in controlling epileptic spasms. Based on the spasm-free rate, a randomized controlled trial has demonstrated the superiority of combining oral steroids and vigabatrin over oral steroids alone but confirmation in real-life conditions is mandatory., Methods: We compared two real-life IESS cohorts: a multicenter, retrospective cohort of 40 infants treated with vigabatrin followed by a sequential (ST) addition of steroids, and a prospective, single-center cohort of 58 infants treated with an immediate combination of vigabatrin and steroids (CT)., Results: The two cohorts were similar. When the rate of spasm-free infants in the two cohorts was compared on day 14, a significant difference was observed between the ST (27,5 %) and CT cohorts (64 %) (p < 0.0004). This difference remained significant on day 30, with 55 % spasm-free patients in the ST cohort compared to 76 % in the CT cohort (p = 0.03). After the infants had received both vigabatrin and steroids, without taking into account the time point after treatment initiation, no significant difference was observed in the spasm-free rate between the two cohorts (p = 0.38)., Interpretation: Real-life data confirm the interest of combination therapy as a first-line treatment for IESS., (© 2023 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.)
- Published
- 2024
- Full Text
- View/download PDF
50. GluK2 Is a Target for Gene Therapy in Drug-Resistant Temporal Lobe Epilepsy.
- Author
-
Boileau C, Deforges S, Peret A, Scavarda D, Bartolomei F, Giles A, Partouche N, Gautron J, Viotti J, Janowitz H, Penchet G, Marchal C, Lagarde S, Trebuchon A, Villeneuve N, Rumi J, Marissal T, Khazipov R, Khalilov I, Martineau F, Maréchal M, Lepine A, Milh M, Figarella-Branger D, Dougy E, Tong S, Appay R, Baudouin S, Mercer A, Smith JB, Danos O, Porter R, Mulle C, and Crépel V
- Subjects
- Humans, Mice, Animals, Temporal Lobe, Hippocampus, Seizures, Epilepsy, Temporal Lobe therapy, Drug Resistant Epilepsy genetics, Drug Resistant Epilepsy therapy, MicroRNAs
- Abstract
Objective: Temporal lobe epilepsy (TLE) is characterized by recurrent seizures generated in the limbic system, particularly in the hippocampus. In TLE, recurrent mossy fiber sprouting from dentate gyrus granule cells (DGCs) crea an aberrant epileptogenic network between DGCs which operates via ectopically expressed GluK2/GluK5-containing kainate receptors (KARs). TLE patients are often resistant to anti-seizure medications and suffer significant comorbidities; hence, there is an urgent need for novel therapies. Previously, we have shown that GluK2 knockout mice are protected from seizures. This study aims at providing evidence that downregulating KARs in the hippocampus using gene therapy reduces chronic epileptic discharges in TLE., Methods: We combined molecular biology and electrophysiology in rodent models of TLE and in hippocampal slices surgically resected from patients with drug-resistant TLE., Results: Here, we confirmed the translational potential of KAR suppression using a non-selective KAR antagonist that markedly attenuated interictal-like epileptiform discharges (IEDs) in TLE patient-derived hippocampal slices. An adeno-associated virus (AAV) serotype-9 vector expressing anti-grik2 miRNA was engineered to specifically downregulate GluK2 expression. Direct delivery of AAV9-anti grik2 miRNA into the hippocampus of TLE mice led to a marked reduction in seizure activity. Transduction of TLE patient hippocampal slices reduced levels of GluK2 protein and, most importantly, significantly reduced IEDs., Interpretation: Our gene silencing strategy to knock down aberrant GluK2 expression demonstrates inhibition of chronic seizure in a mouse TLE model and IEDs in cultured slices derived from TLE patients. These results provide proof-of-concept for a gene therapy approach targeting GluK2 KARs for drug-resistant TLE patients. ANN NEUROL 2023;94:745-761., (© 2023 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.